Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126038441 | 12603844 | 1 | I | 20140727 | 20160713 | 20160728 | 20160728 | EXP | CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062294 | BRISTOL MYERS SQUIBB | 57.00 | YR | M | Y | 0.00000 | 20160728 | CN | GB | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126038441 | 12603844 | 1 | I | AMIKACIN SULFATE. | AMIKACIN SULFATE | 1 | Intravenous (not otherwise specified) | 900 MG, UNK | U | 0 | 900 | MG | QD | ||||||
| 126038441 | 12603844 | 2 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | U | 9218 | ||||||||||
| 126038441 | 12603844 | 3 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | 500 MG, BID | U | 0 | 500 | MG | BID | ||||||
| 126038441 | 12603844 | 4 | I | IMIPENEM | IMIPENEM | 1 | Intravenous (not otherwise specified) | 500 MG, Q6H | U | 0 | 500 | MG | QID | ||||||
| 126038441 | 12603844 | 5 | C | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | 1 G, Q8H | U | 0 | 1 | G | TID | ||||||
| 126038441 | 12603844 | 6 | C | ISONIAZID. | ISONIAZID | 1 | Unknown | U | 0 | ||||||||||
| 126038441 | 12603844 | 7 | C | RIFAMPIN. | RIFAMPIN | 1 | Unknown | U | 0 | ||||||||||
| 126038441 | 12603844 | 8 | C | PYRAZINAMIDE. | PYRAZINAMIDE | 1 | Unknown | U | 0 | ||||||||||
| 126038441 | 12603844 | 9 | C | ETHAMBUTOL | ETHAMBUTOL HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 500 MG, UNK | U | 0 | 500 | MG | |||||||
| 126038441 | 12603844 | 10 | C | PENICILLIN /00000901/ | PENICILLIN G | 1 | Oral | U | 0 | ||||||||||
| 126038441 | 12603844 | 11 | C | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 4.5 G, UNK | U | 0 | 4.5 | G | |||||||
| 126038441 | 12603844 | 12 | C | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 1.25 G, UNK | U | 0 | 1.25 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126038441 | 12603844 | 1 | Mycobacterial infection |
| 126038441 | 12603844 | 2 | Anticoagulant therapy |
| 126038441 | 12603844 | 3 | Product used for unknown indication |
| 126038441 | 12603844 | 4 | Product used for unknown indication |
| 126038441 | 12603844 | 5 | Product used for unknown indication |
| 126038441 | 12603844 | 6 | Product used for unknown indication |
| 126038441 | 12603844 | 7 | Product used for unknown indication |
| 126038441 | 12603844 | 8 | Product used for unknown indication |
| 126038441 | 12603844 | 9 | Product used for unknown indication |
| 126038441 | 12603844 | 10 | Product used for unknown indication |
| 126038441 | 12603844 | 11 | Product used for unknown indication |
| 126038441 | 12603844 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126038441 | 12603844 | OT |
| 126038441 | 12603844 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126038441 | 12603844 | Drug interaction | |
| 126038441 | 12603844 | Gastrointestinal haemorrhage | |
| 126038441 | 12603844 | International normalised ratio increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126038441 | 12603844 | 1 | 20140707 | 0 |